How pharmacists are changing myeloma care

Francesca McArthur
Published:
Sign up to join the conversation
Members only

When I first entered this role, my responsibilities were mainly focused on the technical aspects of treatment delivery. This included verifying chemotherapy prescriptions and ensuring compliance with pregnancy prevention programme requirements. However, the treatment landscape for myeloma has evolved considerably over recent years, and with it, the scope of my role has expanded too.

Sign up and become a member of the Myeloma UK HCP Hub

Access exclusive content like this and join in the conversation.

Already have an account?